Amneal Pharmaceuticals (AMRX) Change in Cash (2017 - 2026)

Amneal Pharmaceuticals' Change in Cash history runs 10 years deep, the most recent figure standing at -$108.5 million for Q1 2026.

• In Q1 2026, Change in Cash fell 116.95% year-over-year to -$108.5 million; the TTM figure through Mar 2026 stood at $136.0 million (up 710.72% YoY), while the FY2025 annual figure was $194.5 million, up 907.19% from the prior year.
• Change in Cash was -$108.5 million for Q1 2026 at Amneal Pharmaceuticals, down from $74.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $154.7 million in Q3 2025 to a low of -$118.4 million in Q2 2022.
• Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of -$2.3 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Cash sank 728.24% in 2023, then jumped 1045.0% in 2024.
• A 5-year view of Change in Cash shows it stood at -$60.7 million in 2022, then jumped by 105.77% to $3.5 million in 2023, then surged by 1045.0% to $40.1 million in 2024, then surged by 85.98% to $74.5 million in 2025, then sank by 245.62% to -$108.5 million in 2026.
• The last three Change in Cash figures came in at -$108.5 million (Q1 2026), $74.5 million (Q4 2025), and $154.7 million (Q3 2025), per Business Quant data.